Quantbot Technologies LP Invests $600,000 in Establishment Labs Holdings Inc. $ESTA

Quantbot Technologies LP purchased a new stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) in the 2nd quarter, HoldingsChannel reports. The firm purchased 6,997 shares of the company’s stock, valued at approximately $600,000.

A number of other large investors also recently bought and sold shares of ESTA. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Establishment Labs by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 57,215 shares of the company’s stock worth $2,335,000 after purchasing an additional 9,557 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Establishment Labs by 1.2% during the 2nd quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock valued at $1,105,000 after buying an additional 299 shares in the last quarter. WINTON GROUP Ltd acquired a new stake in Establishment Labs in the 2nd quarter valued at $651,000. Nebula Research & Development LLC grew its stake in Establishment Labs by 27.9% in the 2nd quarter. Nebula Research & Development LLC now owns 16,214 shares of the company’s stock valued at $692,000 after acquiring an additional 3,538 shares during the period. Finally, Sei Investments Co. increased its holdings in Establishment Labs by 13.3% in the 2nd quarter. Sei Investments Co. now owns 48,428 shares of the company’s stock worth $2,068,000 after acquiring an additional 5,668 shares in the last quarter. Institutional investors and hedge funds own 72.91% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Needham & Company LLC increased their price objective on shares of Establishment Labs from $86.00 to $95.00 and gave the company a “buy” rating in a report on Thursday, August 6th. JPMorgan Chase & Co. boosted their target price on shares of Establishment Labs from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, August 7th. BTIG Research lifted their price objective on Establishment Labs from $96.00 to $103.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Establishment Labs in a research note on Wednesday, June 24th. Finally, TD Cowen increased their target price on Establishment Labs from $95.00 to $117.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Eight equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, Establishment Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $100.25.

Establishment Labs Price Performance

Establishment Labs stock opened at $71.80 on Friday. The company has a fifty day simple moving average of $85.28 and a 200-day simple moving average of $74.94. The firm has a market capitalization of $2.14 billion, a price-to-earnings ratio of -54.81 and a beta of 1.07. The company has a quick ratio of 2.52, a current ratio of 3.84 and a debt-to-equity ratio of 12.11. Establishment Labs Holdings Inc. has a 52-week low of $36.53 and a 52-week high of $97.59.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.05). The business had revenue of $67.54 million during the quarter, compared to analysts’ expectations of $65.79 million. Establishment Labs had a negative return on equity of 196.69% and a negative net margin of 15.82%.The business’s quarterly revenue was up 31.7% on a year-over-year basis. During the same period in the prior year, the business posted ($0.57) earnings per share. On average, equities analysts anticipate that Establishment Labs Holdings Inc. will post -1.15 EPS for the current fiscal year.

Establishment Labs Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.